DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 966 filers reported holding DANAHER CORPORATION in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $595,440 | +3.4% | 2,400 | 0.0% | 0.14% | +2.3% |
Q2 2023 | $576,000 | -4.8% | 2,400 | 0.0% | 0.13% | -7.7% |
Q1 2023 | $604,896 | -5.0% | 2,400 | 0.0% | 0.14% | -7.1% |
Q4 2022 | $637,008 | -3.3% | 2,400 | -5.9% | 0.15% | -16.3% |
Q3 2022 | $659,000 | +2.0% | 2,550 | 0.0% | 0.18% | +5.1% |
Q2 2022 | $646,000 | -13.6% | 2,550 | 0.0% | 0.18% | +1.7% |
Q1 2022 | $748,000 | -14.2% | 2,550 | -3.8% | 0.17% | -9.9% |
Q4 2021 | $872,000 | +8.1% | 2,650 | 0.0% | 0.19% | -8.2% |
Q3 2021 | $807,000 | +13.5% | 2,650 | 0.0% | 0.21% | +13.0% |
Q2 2021 | $711,000 | +16.6% | 2,650 | -2.2% | 0.18% | +5.1% |
Q1 2021 | $610,000 | +1.8% | 2,710 | +0.4% | 0.18% | -8.4% |
Q4 2020 | $599,000 | -4.0% | 2,700 | -6.9% | 0.19% | -12.8% |
Q3 2020 | $624,000 | +21.6% | 2,900 | 0.0% | 0.22% | +10.1% |
Q2 2020 | $513,000 | +23.9% | 2,900 | -3.3% | 0.20% | +2.1% |
Q1 2020 | $414,000 | -10.0% | 3,000 | 0.0% | 0.20% | +16.1% |
Q4 2019 | $460,000 | +6.0% | 3,000 | 0.0% | 0.17% | -5.1% |
Q3 2019 | $434,000 | -2.0% | 3,000 | -3.2% | 0.18% | -8.3% |
Q2 2019 | $443,000 | +8.0% | 3,100 | 0.0% | 0.19% | +3.2% |
Q1 2019 | $410,000 | +24.6% | 3,100 | -3.1% | 0.19% | +8.1% |
Q4 2018 | $329,000 | -5.5% | 3,200 | 0.0% | 0.17% | +13.8% |
Q3 2018 | $348,000 | +10.8% | 3,200 | 0.0% | 0.15% | 0.0% |
Q2 2018 | $314,000 | 0.0% | 3,200 | 0.0% | 0.15% | -4.4% |
Q1 2018 | $314,000 | +5.7% | 3,200 | 0.0% | 0.16% | +6.0% |
Q4 2017 | $297,000 | +8.0% | 3,200 | 0.0% | 0.15% | -3.8% |
Q3 2017 | $275,000 | -1.4% | 3,200 | -3.0% | 0.16% | -4.9% |
Q2 2017 | $279,000 | -1.1% | 3,300 | 0.0% | 0.16% | -3.5% |
Q1 2017 | $282,000 | +9.7% | 3,300 | 0.0% | 0.17% | +4.9% |
Q4 2016 | $257,000 | -0.4% | 3,300 | 0.0% | 0.16% | -1.8% |
Q3 2016 | $258,000 | -22.5% | 3,300 | 0.0% | 0.16% | -25.7% |
Q2 2016 | $333,000 | +6.1% | 3,300 | 0.0% | 0.22% | +4.2% |
Q1 2016 | $314,000 | -11.3% | 3,300 | -13.2% | 0.21% | -9.4% |
Q4 2015 | $354,000 | -4.6% | 3,800 | -12.6% | 0.24% | -10.0% |
Q3 2015 | $371,000 | -0.5% | 4,350 | 0.0% | 0.26% | +9.2% |
Q2 2015 | $373,000 | +1.4% | 4,350 | 0.0% | 0.24% | +0.4% |
Q1 2015 | $368,000 | -1.3% | 4,350 | 0.0% | 0.24% | -3.3% |
Q4 2014 | $373,000 | +13.4% | 4,350 | 0.0% | 0.25% | +10.3% |
Q3 2014 | $329,000 | -3.5% | 4,350 | 0.0% | 0.22% | -3.5% |
Q2 2014 | $341,000 | +0.3% | 4,350 | -3.3% | 0.23% | -5.7% |
Q1 2014 | $340,000 | – | 4,500 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |